The tumor suppressor p53 is inactivated by genetic mutations in many cancers, except for neuroblastoma. New findings show that this cancer reversibly inhibits p53 through a microRNA, miR-380-5p (pages 1134–1140). Blocking it to restore p53 function may be an attractive therapeutic option for neuroblastomas.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
MicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicity
BMC Cancer Open Access 02 May 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
£139.00 per year
only £11.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Vogelstein, B., Lane, D.D. & Levine, A.A.J. Nature 408, 307–310 (2000).
Menendez, D., Inga, A. & Resnick, M.A. Nat. Rev. Cancer 9, 724–737 (2009).
Xue, W. et al. Nature 445, 656–660 (2007).
Swarbrick, A. et al. Nat. Med. 16, 1134–1140 (2010).
Bartel, D.P. Cell 116, 281–297 (2004).
He, L., He, X., Lowe, S.W. & Hannon, G.J. Nat. Rev. Cancer 7, 819–822 (2007).
Bailey, S.G., Sanchez-Elsner, T., Stephanou, A., Cragg, M.S. & Townsend, P.A. Apoptosis 15, 541–552 (2010).
Maris, J.M. N. Engl. J. Med. 362, 2202–2211 (2010).
Schulte, J.H. et al. Int. J. Cancer published online, doi:10.1002/ijc.25436 (1 July 2010).
Welch, C., Chen, Y. & Stallings, R.L. Oncogene 26, 5017–5022 (2007).
Hermeking, H. Cell Death Differ. 17, 193–199 (2010).
Le, M.T. et al. Genes Dev. 23, 862–876 (2009).
Hu, W. et al. Mol. Cell 38, 689–699 (2010).
Guan, Y. et al. Int. J. Cancer published online, doi:10.1002/ijc.25575 (23 July 2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Eggert, A., Schulte, J. A small kiss of death for cancer. Nat Med 16, 1079–1081 (2010). https://doi.org/10.1038/nm1010-1079
Issue Date:
DOI: https://doi.org/10.1038/nm1010-1079